ZA201009063B - Diaryl ureas for treating heart failure - Google Patents

Diaryl ureas for treating heart failure

Info

Publication number
ZA201009063B
ZA201009063B ZA2010/09063A ZA201009063A ZA201009063B ZA 201009063 B ZA201009063 B ZA 201009063B ZA 2010/09063 A ZA2010/09063 A ZA 2010/09063A ZA 201009063 A ZA201009063 A ZA 201009063A ZA 201009063 B ZA201009063 B ZA 201009063B
Authority
ZA
South Africa
Prior art keywords
heart failure
treating heart
diaryl ureas
diaryl
ureas
Prior art date
Application number
ZA2010/09063A
Other languages
English (en)
Inventor
Barbara Albrecht-Kupper
Stefan Schafer
Elodie Kienlen
Original Assignee
Bayer Schering Pharma Aktiengesellscaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Aktiengesellscaft filed Critical Bayer Schering Pharma Aktiengesellscaft
Publication of ZA201009063B publication Critical patent/ZA201009063B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2010/09063A 2008-06-25 2010-12-17 Diaryl ureas for treating heart failure ZA201009063B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08011471 2008-06-25
PCT/EP2009/004390 WO2009156089A1 (en) 2008-06-25 2009-06-18 Diaryl ureas for treating heart failure

Publications (1)

Publication Number Publication Date
ZA201009063B true ZA201009063B (en) 2012-02-29

Family

ID=41136709

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/09063A ZA201009063B (en) 2008-06-25 2010-12-17 Diaryl ureas for treating heart failure

Country Status (13)

Country Link
US (1) US20110263657A1 (enExample)
EP (1) EP2293792A1 (enExample)
JP (1) JP2011525506A (enExample)
KR (1) KR20110031294A (enExample)
CN (1) CN102076338A (enExample)
AU (1) AU2009262599A1 (enExample)
BR (1) BRPI0914636A2 (enExample)
CA (1) CA2729050A1 (enExample)
IL (1) IL209647A0 (enExample)
MX (1) MX2010014441A (enExample)
RU (1) RU2011102471A (enExample)
WO (1) WO2009156089A1 (enExample)
ZA (1) ZA201009063B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718703B (zh) * 2011-03-31 2016-09-14 中国医学科学院药物研究所 Gk和ppar双重激动活性的含有二甲基的芳基脲类衍生物
EP2723718A1 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
AP2013007331A0 (en) 2011-06-24 2013-12-31 Amgen Inc TRPM8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
RU2646454C2 (ru) * 2013-11-12 2018-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Способ моделирования алкогольной кардиомиопатии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636585B2 (en) * 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
PL1663978T3 (pl) * 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
WO2009092442A1 (en) * 2008-01-23 2009-07-30 Universidad De Barcelona Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways

Also Published As

Publication number Publication date
AU2009262599A1 (en) 2009-12-30
IL209647A0 (en) 2011-02-28
JP2011525506A (ja) 2011-09-22
KR20110031294A (ko) 2011-03-25
MX2010014441A (es) 2011-01-21
BRPI0914636A2 (pt) 2015-10-20
US20110263657A1 (en) 2011-10-27
CN102076338A (zh) 2011-05-25
CA2729050A1 (en) 2009-12-30
EP2293792A1 (en) 2011-03-16
WO2009156089A1 (en) 2009-12-30
RU2011102471A (ru) 2012-07-27

Similar Documents

Publication Publication Date Title
IL215975A (en) Heart failure device
SG10201503135RA (en) Agent for treating disease
IL207892A0 (en) Agent for treating disease
IL209895A0 (en) Compounds for treating beta-amyloidoses
EP2322076A4 (en) ENDOSCOPE OF TREATMENT
IL207891A0 (en) Agent for treating disease
EP2225002A4 (en) RNA INTERFERENCE FOR THE TREATMENT OF CARDIAC SUFFICIENCIES
GB0823213D0 (en) Treatment
GB0802116D0 (en) Treatment
GB0822011D0 (en) Treatment
PL1987765T3 (pl) Oksymetr
IL207584A0 (en) Treating hypertension with 25-hydroxyvitamin d3
PL2441462T3 (pl) Sposób leczenia cukrzycy typu I
GB0800791D0 (en) Composition for treating a skin disorder
GB0811992D0 (en) Treatment
PT2341937E (pt) Composição para tratamento de doença
IL209647A0 (en) Diaryl ureas for treating heart failure
IL234693A0 (en) Adiponectin for the treatment of lung disease
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
IL207906A0 (en) Treatment for ocular-related disorders
GB0820972D0 (en) Treatment
GB0805912D0 (en) Treatment
GB0814722D0 (en) Treatment monitoring
ZA201101773B (en) Compositions and methods for treating heart failure
GB0707090D0 (en) Composition for treating a skin disorder